JAHA:社区暴力犯罪与心血管疾病死亡率之间的关系

2022-07-17 MedSci原创 MedSci原创

从2000年到2014年,芝加哥社区暴力犯罪率的大幅下降与心血管疾病和冠状动脉疾病死亡率的大幅下降有关。

最近,美国许多大城市的暴力犯罪都有所增加。先前的研究表明,社区犯罪水平与心血管疾病之间存在关联,但许多研究都受到了横断面设计的限制。

近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员分析了暴力犯罪率的纵向变化是否与社区水平心血管死亡率的变化相关。

美国芝加哥由77个社区组成,研究人员对2000-2014年社区心血管疾病、卒中和冠状动脉疾病的年龄调整死亡率,每5年汇总一次,数据来自伊利诺伊州公共卫生部门生命记录司。按社区划分的平均总犯罪率和暴力犯罪率来自芝加哥市警察数据门户网站,并通过使用双向固定效应估计。研究人员评估了2000年至2014年社区区域层面的人群、经济变量变化和长期时间趋势后,暴力犯罪纵向变化与心血管死亡率之间的关联。

2000年至2014年间,芝加哥的暴力犯罪率中位数从2000年至2004年间的每10万人中3620人(四分位差范围为2256-7777)下降到2010年至2014年间的每10万人中2390人(四分位差范围为1507-5745)(趋势P=0.005)。在固定效应模型中,社区暴力犯罪率下降1%与心血管疾病死亡率下降0.21%(95%CI为0.09-0.33)和冠状动脉疾病死亡率下降0.19%(95%CI为0.04-0.33)相关(P=0.01)。暴力犯罪的变化与卒中死亡率之间没有统计学上的显著关联(-0.17%[95%CI为-0.42-0.08;P=0.18)。

由此可见,从2000年到2014年,芝加哥社区暴力犯罪率的大幅下降与心血管疾病和冠状动脉疾病死亡率的大幅下降有关。这些结果为维持社会治安环境对健康的影响提供了越来越多的证据,并表明暴力犯罪是心血管健康的潜在社会决定因素。对社区进行有针对性的投资以减少暴力犯罪,可改善社区心血管健康。

 

原始出处:

Lauren A. Eberly.et al.Association Between Community‐Level Violent Crime and Cardiovascular Mortality in Chicago: A Longitudinal Analysis.JAHA.2022.https://www.ahajournals.org/doi/10.1161/JAHA.122.025168

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2083674, encodeId=fd0f20836e4c9, content=<a href='/topic/show?id=793c601e73a' target=_blank style='color:#2F92EE;'>#暴力犯罪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60177, encryptionId=793c601e73a, topicName=暴力犯罪)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Thu Nov 24 02:59:14 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268864, encodeId=72bf1268864ef, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395931, encodeId=e894139593180, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499085, encodeId=56821499085ad, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2083674, encodeId=fd0f20836e4c9, content=<a href='/topic/show?id=793c601e73a' target=_blank style='color:#2F92EE;'>#暴力犯罪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60177, encryptionId=793c601e73a, topicName=暴力犯罪)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Thu Nov 24 02:59:14 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268864, encodeId=72bf1268864ef, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395931, encodeId=e894139593180, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499085, encodeId=56821499085ad, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=)]
    2022-07-19 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=2083674, encodeId=fd0f20836e4c9, content=<a href='/topic/show?id=793c601e73a' target=_blank style='color:#2F92EE;'>#暴力犯罪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60177, encryptionId=793c601e73a, topicName=暴力犯罪)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Thu Nov 24 02:59:14 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268864, encodeId=72bf1268864ef, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395931, encodeId=e894139593180, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499085, encodeId=56821499085ad, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2083674, encodeId=fd0f20836e4c9, content=<a href='/topic/show?id=793c601e73a' target=_blank style='color:#2F92EE;'>#暴力犯罪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60177, encryptionId=793c601e73a, topicName=暴力犯罪)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Thu Nov 24 02:59:14 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268864, encodeId=72bf1268864ef, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395931, encodeId=e894139593180, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499085, encodeId=56821499085ad, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jul 19 00:59:14 CST 2022, time=2022-07-19, status=1, ipAttribution=)]

相关资讯

JAHA:ST段抬高型心肌梗死患者神经肽Y水平与冠状动脉微血管功能、心力衰竭和死亡率的关系

ST段抬高心肌梗死后,外周静脉和冠状静脉窦NPY水平与微血管功能和梗死面积相关。外周静脉NPY水平与随后的心衰发展或死亡率相关,因此它可能是一个有用的预后标志。

Nature子刊:相比中年,老年外科医生手术患者死亡风险反而升高14%!

Scientifc Reports:外科医生年龄与术后并发症/死亡率的关系:队列研究的系统回顾和荟萃分析

JNNP:澳大利亚塔斯马尼亚州大霍巴特多发性硬化症的发病率和患病率增加

多发性硬化(MS)是一种复杂的神经疾病。环境和生活方式因素与多发性硬化症的发病有关,这些因素在多发性硬化症遗传风险增加的患者中尤为重要。澳大利亚塔斯马尼亚州的大霍巴特地区是主要的多发性硬化症流行病学研

Ann Phys Rehabil Med: 五次重复坐站试验对慢性阻塞性肺疾病患者死亡率的预后价值

慢阻肺一般指慢性阻塞性肺疾病。 慢性阻塞性肺疾病是一种具有气流阻塞特征的慢性支气管炎和(或)肺气肿,可进一步发展为肺心病和呼吸衰竭的常见慢性疾病。

Crit Care:血管外肺水含量与死亡率相关

TPTD测量的EVLW值与危重患者的死亡率相关,非存活患者明显高于存活患者。这一结果可能被解释间接证实了在床边通过TPTD估计EVLW的可靠性。